Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LILIPSY: Liquid Biopsy in HCC
NCT05810402Recruiting
- Sponsor
- CHU Montpellier
- Start
- Jun 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU Montpellier. Primary endpoint: Percentage of patients with CTCs-PD-L1+ by CellSearch® technique. Started Jun 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05810402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05810402.